• 1
    Farrel J, Gellens M. Ultrasound-guided cannulation versus the landmark-guided technique for acute hemodialysis access. Nephrol Dial Transplant. 1997; 12: 12341237.
  • 2
    Hind D, Calvert N, McWilliams R, et al. Ultrasonic locating devices for central venous cannulation: Metaanalysis. BMJ. 2003; 327(7411): 361.
  • 3
    Parienti JJ, Thirion M, Megarbane B, et al; Members of the Cathedia Study Group. Femoral versus jugular venous catheterization and risk of nosocomial events in adults requiring acute renal replacement therapy: a randomized controlled trial. JAMA. 2008; 299: 24132422.
  • 4
    Zollo A, Cavatorta F, Galli S. Ultrasound-guided cannulation of the femoral vein for acute hemodialysis access with silicone catheters. J Vasc Access. 2001; 2: 5659.
  • 5
    Heinz J, Kropf S, Domrose U, et al. B vitamins and the risk of total mortality and cardiovascular disease in end-stage renal disease: results of a randomized controlled trial. Circulation. 2010; 121: 13791381.
  • 6
    Heinz J, Kropf S, Luley C, et al. Homocysteine as a risk factor for cardiovascular disease in patients treated with dialysis: a metaanalysis. Am J Kidney Dis. 2009; 54: 478489.
  • 7
    Vianna AC, Mocelin AJ, Matsuo T et al. Uremic hyperhomocysteinema: a randomized trial of folate treatment for the prevention of cardiovascular events. Hemodialysis Intern. 2007; 11: 210216.
  • 8
    Marti-Carvajal AJ, Sola I, Lathyris D, et al. Homocysteine lowering interventions for preventing cardiovascular events (review). The Cochrane Collaboration. 2009; 165
  • 9
    House AA, Eliasziw M, Cattran DC, et al. Effect of B-vitamin therapy on progression of diabetic nephropathy. JAMA. 2010; 303: 16031609.
  • 10
    Heinz J, Domršse U, Luley C, et al. Influence of a supplementation with vitamins on cardiovascular morbidity and mortality in patients with end-stage renal disease: design and baseline data of a randomized clinical trial. Clin Nephrol. 1999; 71: 363365.
  • 11
    Loscalzo J. Homocysteine trials: clear outcomes for complex reasons. N Engl J Med. 2006; 354: 16291632.
  • 12
    Mujais D, Nolph K, Gokal R, et al. Evaluation and management of ultrafiltration problems in peritoneal dialysis. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis. Perit Dial Int. 2000; 20: S5S21.
  • 13
    Ioannidis JP, Haidich AB, Pappa M, et al. Comparison of evidence of treatment effects in randomized and nonrandomized studies. JAMA. 2001; 286: 821830.
  • 14
    Kunz R, Vist GE, Oxman AD. Randomisation to protect against selection bias in healthcare trials. Cochrane Database Syst Rev. 2007; 2. doi: 10.1002/14651858.MR000012.pub2.